Claims that do not hold up
The Food and Drug Administration, called FDA, reviews medicines.
A claim that a compounded, or made-to-order, drug has FDA approval is false.
FDA warns about care sites that claim a compounded medicine is the same as an approved drug.
Nevada's medical-board ad rules prohibit guarantees of treatment results and misleading price claims.
These ad rules apply to people licensed by Nevada's medical board.
Ask for the treating person's name and license record, plus the pharmacy's name.
A label deserves its own check
Some labels on compounded semaglutide and tirzepatide carry false pharmacy details that FDA has found, including names for nonexistent pharmacies.
Reports to FDA describe errors in the amount of compounded semaglutide people took; some people needed hospital care.
Take a question about a label or an unclear instruction to the pharmacist and prescriber. Ask them to explain it directly.
The body uses a signal called GLP-1 in appetite and blood sugar control. Medicines based on this signal are used for diabetes and weight care.
FDA advises leaving a GLP-1 injection unused if it is delivered warm or was not kept cold enough.
Take a delivery concern to the pharmacy and ask how to deal with it.
Urgent symptoms need urgent help
MedlinePlus describes severe allergic reactions as life-threatening and directs people with severe symptoms to call 911 or seek an emergency room.
The symptom list includes difficulty swallowing or breathing, along with a swollen tongue or face.
The US National Library of Medicine provides health information through its MedlinePlus service.